ArticleCureus2025
Assessing Macular Vessel Density in Iraqi Cone Dystrophy Patients Using Optical Coherence Tomography Angiography (OCTA): A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Cone dystrophy is a hereditary retinopathy characterized by profound vision loss resulting from the degeneration of photoreceptors. Optical coherence tomography angiography (OCTA) is a technique that non-invasively visualizes the microvasculatures of the retina and choroid in detail. This study evaluates macular vessel density in Iraqi patients diagnosed with cone dystrophy using OCTA and makes a comparison with those of healthy controls. Methods The cross-sectional study was conducted at the Gazi Al-Harrir for Surgical Specialty Hospital from December 2021 to May 2024. Twenty-eight patients diagnosed with cone dystrophy and 28 healthy controls were evaluated based on measurement of best corrected visual acuity and thorough funduscopic examination. OCTA assessment of macular vessel density was performed in the central, superior, inferior, nasal, and temporal regions. All the statistical analyses were done with the software Jamovi (https://www.jamovi.org/): descriptive statistics, Shapiro-Wilk tests for normality, and independent samples t-tests. Results The mean central retinal thickness (CRT) was significantly lower in the cone dystrophy group (180.8 µm) compared to the control group (238.8 µm). Regarding macular vessel density, no significant differences were observed between the cone dystrophy and control groups in the central (13.4 µm vs. 17.7 µm, p = 0.234), superior (51.1 µm vs. 48.7 µm, p = 0.400), nasal (44.2 µm vs. 43.4 µm, p = 0.544), and temporal (45.1 µm vs. 45.5 µm, p = 0.202) regions. However, in the inferior region, a significant reduction in macular vessel density was observed in the control group compared to cone dystrophy patients (48.7 µm vs. 46.7 µm, p = 0.008). The Shapiro-Wilk test confirmed normal distribution for most parameters, and significant differences were identified using t-tests. Conclusion This study confirms that the macular vessel density is significantly reduced in Iraqi patients with cone dystrophy. OCTA proves to be a valuable tool for detecting these vascular changes that could act as biomarkers for the severity and progression of this disease. Longitudinal studies in the future are necessary to know more about these vascular alterations and their implications for treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.